🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsSemaglutide albumin binding and the C-18 fatty acid linker — 12 month update Page 5

Semaglutide albumin binding and the C-18 fatty acid linker — 12 month update

LindaRN_retired Wed, Feb 7, 2024 at 11:54 AM 31 replies 2,291 viewsPage 5 of 7
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Feb 8, 2024 at 6:09 PM#21

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Feb 8, 2024 at 9:09 PM
44 19nick_newbie, DadBodDave, AmyNC_wife and 41 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Feb 9, 2024 at 12:37 AM#22
COA_Karl said:
The mechanism is more central than most summaries suggest.

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

43 18HPLC_Greg, LibrarianMeg, bri_stats and 40 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Feb 9, 2024 at 7:05 AM#23
COA_Karl said:
The mechanism is more central than most summaries suggest.

Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were relying on physical fullness feel the effect fade while the appetite effect is still working.

42 17COA_Karl, MikeFit_NJ, InsuranceTom and 39 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Feb 9, 2024 at 1:33 PM#24
COA_Karl said:
The mechanism is more central than most summaries suggest.

That reframing is the part I needed. Printing the relevant bit and taking it with me.

Last edited: Feb 9, 2024 at 7:33 PM
41 16Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 38 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Feb 9, 2024 at 8:01 PM#25

Adding the clinical framing, because it changes how the question reads. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

40 15Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 37 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register